Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic tools for filariasis elimination programs.

Gary J Weil1, Reda M R Ramzy

  • 1Infectious Diseases Division, Washington University School of Medicine, Campus Box 8051, 660 South Euclid Avenue, St. Louis, MO 63110, USA. gweil@wustl.edu

Trends in Parasitology
|December 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Death to Onchocerciasis and Lymphatic Filariasis (DOLF) project: Accomplishments and ongoing research.

PLoS neglected tropical diseases·2026
Same author

Semi-annual and annual mass drug administration of diethylcarbamazine and albendazole are equally effective regimens for eliminating lymphatic filariasis in Papua New Guinea.

PLoS neglected tropical diseases·2025
Same author

Brugia malayi and other filarial parasite species in animals in areas endemic for lymphatic filariasis in Belitung District, Indonesia.

PLoS neglected tropical diseases·2025
Same author

An Antibody Biomarker Associated with Onchocerca volvulus Microfilariae Identified by Proteomic Analysis of Parasite Tissues Isolated from Paraffin Embedded O. volvulus Nodules by Laser Capture Microdissection.

The American journal of tropical medicine and hygiene·2025
Same author

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial.

The Lancet. Infectious diseases·2025
Same author

Spatial proteomics of Onchocerca volvulus with pleomorphic neoplasms shows local and systemic dysregulation of protein expression.

PLoS neglected tropical diseases·2025
Same journal

Hidden diversity in Trichuris control.

Trends in parasitology·2026
Same journal

The second Cryptosporidium meeting: Edinburgh's parasite deep dive.

Trends in parasitology·2026
Same journal

Evolution of generalism under Muller's ratchet.

Trends in parasitology·2026
Same journal

Next generation in parasitology 2026: Connecting young parasitologists across Europe.

Trends in parasitology·2026
Same journal

Disrupted barriers, evolved risks: toward precision One Health in arthropod allergy.

Trends in parasitology·2026
Same journal

Unveiling malaria history using ancient genomes.

Trends in parasitology·2026
See all related articles

Accurate diagnostics are crucial for the Global Programme to Eliminate Lymphatic Filariasis (GPELF). This review examines available tests and their role in mass drug administration (MDA) strategies and monitoring disease resurgence.

Area of Science:

  • Tropical medicine
  • Infectious diseases
  • Public health

Background:

  • Lymphatic filariasis affects millions globally, necessitating large-scale control programs.
  • The Global Programme to Eliminate Lymphatic Filariasis (GPELF) primarily uses mass drug administration (MDA).
  • Effective diagnostics are vital for MDA program success and disease surveillance.

Purpose of the Study:

  • To review current diagnostic tools for lymphatic filariasis.
  • To assess the utility of these diagnostics across different stages of elimination programs.
  • To inform strategies for MDA distribution, impact assessment, and resurgence monitoring.

Main Methods:

  • Literature review of available diagnostic tests for filariasis.
  • Analysis of diagnostic test applications within the context of GPELF objectives.

Related Experiment Videos

  • Evaluation of diagnostic roles in MDA decision-making and post-MDA surveillance.

    • Main Results:

    • Various diagnostic tests exist, each with specific applications in filariasis control.
    • Diagnostics influence decisions on MDA implementation, treatment efficacy assessment, and program endpoints.
    • Tools are essential for monitoring transmission interruption and detecting resurgence post-MDA suspension.

    Conclusions:

    • Diagnostic tools are indispensable components of the GPELF strategy.
    • Optimizing the use of diagnostics enhances the efficiency and effectiveness of filariasis elimination efforts.
    • Continued development and strategic deployment of diagnostics are key to achieving global filariasis eradication.